BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1771854)

  • 1. [The role of the inadequate expression of HLA class-II molecules on pancreatic beta cells in the pathogenesis of type-1 diabetes mellitus].
    Manov A
    Vutr Boles; 1991; 30(1):14-8. PubMed ID: 1771854
    [No Abstract]   [Full Text] [Related]  

  • 2. C. L. Oakley lecture (1987). The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus.
    Foulis AK
    J Pathol; 1987 Jul; 152(3):141-8. PubMed ID: 3309229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faulty major histocompatibility complex class I function linked to autoimmune diabetes.
    Faustman D
    Transplant Proc; 1992 Dec; 24(6):2874-6. PubMed ID: 1465979
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas.
    Pujol-Borrell R; Todd I; Doshi M; Gray D; Feldmann M; Bottazzo GF
    Clin Exp Immunol; 1986 Jul; 65(1):128-39. PubMed ID: 3098471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate major histocompatibility complex class II expression by thyroid follicular cells in thyroid autoimmune disease and by pancreatic beta cells in type I diabetes.
    Pujol-Borrell R; Todd I; Londei M; Foulis A; Feldmann M; Bottazzo GF
    Mol Biol Med; 1986 Apr; 3(2):159-65. PubMed ID: 3090400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Which factors cause type-1 diabetes?].
    Akerblom HK
    Nord Med; 1992; 107(8-9):204-6, 230. PubMed ID: 1408724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin dependent diabetes mellitus as an autoimmune disease.
    Monos DS; Zmijewski CM
    In Vivo; 1988; 2(1):83-9. PubMed ID: 2979822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The autoimmune mechanisms of the development of insulin-dependent diabetes mellitus].
    Shishko PI
    Ter Arkh; 1991; 63(6):l46-51. PubMed ID: 1948721
    [No Abstract]   [Full Text] [Related]  

  • 9. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathology of type 1 diabetes.
    Campbell IL; Harrison LC
    Mol Biol Med; 1990 Aug; 7(4):299-309. PubMed ID: 2233244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [1990 Apollinaire Bouchardat Prize. Immunology of insulin-dependent diabetes mellitus: in vitro and in vivo study models in animals].
    Boitard C
    Journ Annu Diabetol Hotel Dieu; 1990; ():285-99. PubMed ID: 2195212
    [No Abstract]   [Full Text] [Related]  

  • 12. On the pathogenesis of human type I diabetes: where do we stand?
    Bottazzo GF; Todd I; Schwarz G; Gale EM; Pujol-Borrell R
    Ann Inst Pasteur Immunol; 1987; 138(1):117-23. PubMed ID: 3555538
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice.
    Nishimoto H; Kikutani H; Yamamura K; Kishimoto T
    Nature; 1987 Jul 30-Aug 5; 328(6129):432-4. PubMed ID: 3302721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA, autoimmunity, virus and the pathogenesis of juvenile diabetes mellitus.
    Nerup J; Andersen OO; Christy M; Platz P; Ryder L; Thomsen M; Svejgaard A
    Acta Endocrinol Suppl (Copenh); 1976; 205():167-75. PubMed ID: 793277
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current concept of the pathogenesis of autoimmune type 1 diabetes mellitus].
    Satoh J; Takahashi K; Nakazawa T; Sakata Y; Toyota T
    Nihon Rinsho; 1999 Mar; 57(3):528-33. PubMed ID: 10199128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type 1 diabetes mellitus, autoimmune disease: physiopathologic aspects and practical applications].
    Timsit J; Boitard C; Bach JF
    Ann Biol Clin (Paris); 1991; 49(3):149-53. PubMed ID: 2064084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class II major histocompatibility complex and organ specific autoimmunity in man.
    Foulis AK
    J Pathol; 1986 Sep; 150(1):5-11. PubMed ID: 2946837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the pathogenesis of beta-cell destruction in insulin-dependent diabetes mellitus.
    Lernmark A; Bärmeier H; Dube S; Hagopian W; Karlsen AE; Markholst H; Wilson C; Wassmuth R
    West J Med; 1990 Nov; 153(5):499-502. PubMed ID: 1979704
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible chronological events leading to pancreatic beta cell damage in type I diabetes mellitus.
    Bottazzo GF; Bosi E
    Ann Ital Med Int; 1988; 3 Suppl 1():53-9. PubMed ID: 2978955
    [No Abstract]   [Full Text] [Related]  

  • 20. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.
    Itoh N; Hanafusa T; Miyazaki A; Miyagawa J; Yamagata K; Yamamoto K; Waguri M; Imagawa A; Tamura S; Inada M
    J Clin Invest; 1993 Nov; 92(5):2313-22. PubMed ID: 8227346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.